Open AccessVEGF inhibitors in EGFR-mutated lung cancer: a never-ending story?
Author(s) -
Mariam Alexander,
Balázs Halmos
Publication year - 2018
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2018.11.20
Subject(s) - erlotinib , medicine , lung cancer , oncology , egfr inhibitors , hazard ratio , chemotherapy , tyrosine kinase , t790m , cancer , epidermal growth factor receptor , cancer research , gefitinib , receptor , confidence interval
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom